HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long non-coding NR2F1-AS1 is associated with tumor recurrence in estrogen receptor-positive breast cancers.

Abstract
The tenacity of late recurrence of estrogen receptor (ER)-positive breast cancer remains a major clinical issue to overcome. The administration of endocrine therapies within the first 5 years substantially minimizes the risk of relapse; however, some tumors reappear 10-20 years after the initial diagnosis. Accumulating evidence has strengthened the notion that long noncoding RNAs (lncRNAs) are associated with cancer in various respects. Because lncRNAs may display high tissue/cell specificity, we hypothesized this might provide new insights to tumor recurrence. By comparing transcriptome profiles of 24 clinical primary tumors obtained from patients who developed distant metastases and patients with no signs of recurrence, we identified lncRNA NR2F1-AS1 whose expression was associated with tumor recurrence. We revealed the relationship between NR2F1-AS1 and the hormone receptor expressions in ER-positive breast cancer cells. Gain of function of NR2F1-AS1 steered cancer cells into quiescence-like state by the upregulation of dormancy inducers and pluripotency markers, and activates representative events of the metastatic cascade. Our findings implicated NR2F1-AS1 in the dynamics of tumor recurrence in ER-positive breast cancers and introduce a new biomarker that holds a therapeutic potential, providing favorable prospects to be translated into the clinical field.
AuthorsAnna Sanchez Calle, Tomofumi Yamamoto, Yumi Kawamura, Ai Hironaka-Mitsuhashi, Makiko Ono, Hitoshi Tsuda, Akihiko Shimomura, Kenji Tamura, Fumitaka Takeshita, Takahiro Ochiya, Yusuke Yamamoto
JournalMolecular oncology (Mol Oncol) Vol. 14 Issue 9 Pg. 2271-2287 (09 2020) ISSN: 1878-0261 [Electronic] United States
PMID32392629 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2020 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.
Chemical References
  • RNA, Long Noncoding
  • Receptors, Estrogen
  • Receptors, Progesterone
Topics
  • Animals
  • Breast Neoplasms (genetics, pathology)
  • Cell Cycle (genetics)
  • Cell Line, Tumor
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mice
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local (genetics, pathology)
  • RNA, Long Noncoding (genetics, metabolism)
  • Receptors, Estrogen (metabolism)
  • Receptors, Progesterone (metabolism)
  • Transcription, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: